Bosh sahifaABBV34 ā¢ BVMF
add
AbbVie
Yopilish kursi
80,24Ā R$
Kunlik diapazon
78,72Ā R$ - 79,44Ā R$
Yillik diapazon
59,18Ā R$ - 80,98Ā R$
Bozor kapitalizatsiyasi
403,83Ā mlrd USD
OŹ»rtacha hajm
2,57Ā ming
Narx/foyda
-
Dividend daromadliligi
-
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 15,78Ā mlrd | 9,10% |
Joriy xarajat | 5,72Ā mlrd | -6,46% |
Sof foyda | 186,00Ā mln | -88,08% |
Sof foyda marjasi | 1,18 | -89,07% |
Har bir ulushga tushum | 1,86 | -38,00% |
EBITDA | 7,66Ā mlrd | 23,24% |
Amaldagi soliq stavkasi | 73,67% | ā |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 5,67Ā mlrd | -22,16% |
Jami aktivlari | 133,90Ā mlrd | -6,64% |
Jami passivlari | 136,50Ā mlrd | -0,62% |
Umumiy kapital | -2,60Ā mlrd | ā |
Tarqatilgan aksiyalar | 1,77Ā mlrd | ā |
Narxi/balansdagi bahosi | -53,85 | ā |
Aktivlardan daromad | 10,33% | ā |
Kapitaldan daromad | 20,48% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 186,00Ā mln | -88,08% |
Operatsiyalardan naqd pul | 7,02Ā mlrd | 28,95% |
Sarmoyadan naqd pul | -3,26Ā mlrd | 60,47% |
Moliyadan naqd pul | -4,59Ā mlrd | -49,41% |
Naqd pulning sof oŹ»zgarishi | -838,00Ā mln | 85,73% |
BoŹ»sh pul | 6,23Ā mlrd | 13,88% |
Haqida
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000.
The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
Tashkil etilgan
10-apr, 2012
Sayt
Xodimlar soni
55Ā 000
